Excerpts from analyts' report

trek_flucard-1OSK-DMG analysts: Jarick Seet & Terence Wong,CFA

Trek’s 3Q14 revenue surged 119% YoY to USD35.6m from USD16.3m while its NPAT jumped 144.5% YoY to USD0.76m, driven partially by increased sales to a number of new MNC customers, as well as its toy deal with Rely/Mattel which commenced in 3Q14.

9M14 NPAT to shareholders of SGD1.7m made up 81% of our estimate, well on track.

We expect its wireless Flucard orders from Rely/Mattel to surge, especially in FY15. Maintain BUY and SGD0.61 TP (56% upside).

Toy deal kicking in. Trek 2000 International’s (Trek) initial USD25m deal to supply its signature wireless Flucards to Rely/Mattel (MAT US, NR) commenced in 3Q14. This has led to 3Q14 revenue surging 119% YoY to USD35.6m from USD16.3m, and NPAT leaping 144.5% to USD0.76m from USD0.31m. Licencing revenue in 3Q14 grew 23% to USD0.6m, and may continue to increase going forward as sales increase.

♦ Exciting new projects in the pipeline – Cloud Stringers and consumer solid-state drives (SSDs). We expect the ramp-up of Cloud Stringers, a digital (cloud-based) marketplace that transmits and transacts online content globally, to commence by the end of the year. Furthermore, its partnership with Panasonic (6752 JP, NR) as well as multiple news agencies and freelance journalists could boost the content and number of users of this site. 

In addition, its latest joint venture with Unimicron Technology Corp, a subsidiary of United Microelectronics Corp (UMC) (2303 TT, NR) to produce portable consumer electronics, may potentially contribute to its FY15 earnings. 


henn_1Henn Tan, CEO of Trek 2000.
NextInsight file photo.
♦ Poised for a great leap in FY15; maintain BUY. As the deal with Rely/Mattel just commenced in 3Q, we expect orders to pick up at a fast pace, especially in FY15.

We estimate OEM Flucard sales to double to USD100m in FY15 from USD50m in FY14, with Rely/Mattel contributing a significant portion as it looks to launch an educational toy into the US market by the end of FY14.

Going forward, with a number of exciting new projects lining up, coupled with its strong and successful research and development team, we are very positive on Trek’s outlook and a potential strong comeback in FY15.

Maintain BUY with a SGD0.61 TP, pegged to a 16x FY15 P/E, implying a 56% upside from current levels.

Recent story: TREK 2000: FluCard sales to soar with Mattel partnership, says OSK-DMG

Share Prices

Counter NameLastChange
AEM Holdings3.7300.080
Avi-Tech Electronics0.275-0.015
Best World1.790-0.010
Broadway Ind0.1190.002
China Sunsine0.410-
Food Empire0.6500.030
Fortress Minerals0.345-
Geo Energy Res0.3550.005
Golden Energy0.7750.005
GSS Energy0.047-
ISDN Holdings0.4050.010
IX Biopharma0.127-
Jiutian Chemical0.0760.001
KSH Holdings0.355-
Leader Env0.053-0.007
Medtecs Intl0.147-0.001
Meta Health0.0250.001
Nordic Group0.475-
Oxley Holdings0.1450.001
REX International0.2350.005
Sinostar PEC0.191-
Southern Alliance Mining0.405-
Straco Corp.0.405-
Sunpower Group0.255-
The Trendlines0.0940.001
Totm Technologies0.110-0.004
UG Healthcare0.1990.001
Uni-Asia Group0.8150.015
Wilmar Intl4.0900.030
Yangzijiang Shipbldg1.390-0.020

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 1554 guests and no members online